Evogene Reports $0.63 EPS Loss on $0.68 Million Revenue

Key Facts

1Evogene reported a GAAP EPS loss of $0.63 for the period.

2The company's revenue reached $0.68 million for the quarter.

Evogene reported a GAAP EPS loss of $0.63 for the period. According to company data cited by Seeking Alpha, the firm's revenue reached $0.68 million for the quarter.

EVGN closed at $0.4157 on September 25, 2026, with the session seeing a high of $0.4798 and a low of $0.4157. The financial results reflect the ongoing revenue generation challenges and expected losses typical for firms in this sector.